Biocon Downgrade News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Jefferies has downgraded the pharma stock Biocon to underperform from hold . However, Jefferies has maintained its target price of ₹250 for the stock, implying an 11 percent downside from its current market price of ₹281.50.

Biocon biologicsEconomic timesBiocon stockBiocon share priceBiocon sharesBiocon stock priceJefferies on bioconJefferies downgrades bioconBiocon target priceBiocon downgradeStock marketsMarket newsStock newsBusiness newsBiocon news